Drug Shortage Report for TOBREX
Report ID | 75340 |
Drug Identification Number | 00614254 |
Brand name | TOBREX |
Common or Proper name | TOBREX OINT 3.5G |
Company Name | NOVARTIS PHARMACEUTICALS CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | TOBRAMYCIN |
Strength(s) | 3MG |
Dosage form(s) | OINTMENT |
Route of administration | OPHTHALMIC |
Packaging size | 3.5G |
ATC code | S01AA |
ATC description | ANTIINFECTIVES |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2019-02-11 |
Estimated end date | 2019-03-08 |
Actual end date | 2019-03-08 |
Shortage status | Resolved |
Updated date | 2019-03-09 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 700 RUE SAINT-HUBERT MONTREAL, QUEBEC CANADA H2Y 0C1 |
Company contact information | customer.relations@novartis.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2019-02-11 | English | Compare |
v2 | 2019-02-11 | French | Compare |
v3 | 2019-02-12 | English | Compare |
v4 | 2019-03-01 | English | Compare |
v5 | 2019-03-01 | French | Compare |
v6 | 2019-03-08 | English | Compare |
v7 | 2019-03-08 | French | Compare |
v8 | 2019-03-09 | English | Compare |
Showing 1 to 8 of 8